GENMAB A/S
GMAB·372303206·US·ADR·Healthcare - Biotechnology
GMAB (GENMAB A/S) is held by 106 institutional investors as of Q1 2026. Largest holders: Orbis Allan Gray Ltd ($346.8M), ALLIANCEBERNSTEIN L.P. ($294.4M), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ($133.5M). Net institutional sentiment: Mixed.
106
Holders
Avg rating(14 Elite)
$1.7B
Total Value
49% (127)
Fund Consensus
60 buying - 62 selling
Who's Trading
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Decreased | 12.9M(-10.3%) | $346.8M | 1.5% | +4.79% | 0 | |
Decreased | 9.6M(-12.1%) | $294.4M | 0.1% | -19.83% | 0 | |
Decreased | 5M(-0.1%) | $133.5M | 0.1% | +12.24% | 0 | |
Decreased | 4.5M(-1.3%) | $121.7M | 0.0% | +10.73% | 0 | |
Increased | 4.4M(+26.4%) | $118.4M | 0.2% | -7.24% | 44 | |
Decreased | 3.2M(-4.1%) | $86.7M | 0.9% | -13.59% | 0 | |
Increased | 2.5M(+84.3%) | $66M | 0.0% | -6.36% | 46 | |
Increased | 2.3M(+161.1%) | $62.8M | 0.1% | +2.49% | 48 | |
Increased | 2.2M(+19.1%) | $58.6M | 0.0% | +8.55% | 35 | |
Increased | 1.3M(+84.2%) | $33.6M | 0.1% | -8.51% | 45 | |
Increased | 1.2M(+3792.8%) | $32M | 0.0% | -4.86% | 47 | |
Decreased | 1.1M(-1.9%) | $28.9M | 0.0% | -15.72% | 0 | |
Decreased | 1M(-4.3%) | $27.1M | 0.0% | +10.21% | 0 | |
Decreased | 950,534(-0.7%) | $25.5M | 0.0% | -3.59% | 0 | |
Decreased | 931,259(-30.1%) | $25M | 0.0% | +10.90% | 0 | |
Increased | 862,301(+6.9%) | $23.1M | 0.0% | -20.12% | 31 | |
Increased | 797,068(+12.2%) | $21.4M | 0.0% | +25.64% | 32 | |
Increased | 792,293(+737.8%) | $21.3M | 0.0% | -3.63% | 46 | |
Increased | 677,346(+1616.8%) | $18.2M | 0.0% | -4.82% | 46 | |
Increased | 645,481(+27.4%) | $17.3M | 0.0% | -13.46% | 35 |
Showing 1-20 of 127
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
410 holders · $577.8B
UNHUNITEDHEALTH GROUP INC409 holders · $155.8B
JNJJOHNSON & JOHNSON391 holders · $327.3B
DHRDANAHER CORP DEL388 holders · $82.5B
ISRGINTUITIVE SURGICAL INC388 holders · $102.1B
TMOTHERMO FISHER SCIENTIFIC INC387 holders · $127.1B
BSXBOSTON SCIENTIFIC CORP386 holders · $67.5B
MRKMERCK & CO INC381 holders · $175.6B
ABBVABBVIE INC378 holders · $212.3B
ABTABBOTT LABORATORIES376 holders · $108.9B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer